Activity and spectrum of 22 antimicrobial agents tested against urinary tract infection pathogens in hospitalized patients in Latin America: report from the second year of the SENTRY antimicrobial surveillance program (1998).
about
Antimicrobial resistance among producers and non-producers of extended spectrum beta-lactamases in urinary isolates at a tertiary Hospital in Tanzania.Multidrug-resistant urinary tract isolates of Escherichia coli: prevalence and patient demographics in the United States in 2000.Spontaneous conversion to quinolone and fluoroquinolone resistance among wild-type Escherichia coli isolates in relation to phylogenetic background and virulence genotype.Bacterial resistance in urinary tract infections: how to stem the tide.Antibiotic Susceptibility Pattern of ESβL Producing Klebsiella pneumoniae Isolated from Urine Samples of Pregnant Women in Karnataka.Isolation and molecular characterization of nalidixic acid-resistant extraintestinal pathogenic Escherichia coli from retail chicken products.Fluoroquinolone-resistant uncomplicated urinary tract infections, Chinese herbal medicine may provide help.Antibiotic treatment for urinary tract infections: pharmacokinetic/pharmacodynamic principles.Antibiotic sensitivity and resistance in children with urinary tract infection in SanliurfaEmerging drugs for bacterial urinary tract infections.The treatment of urinary tract infections and use of ciprofloxacin extended release.Urinary tract infection among symptomatic outpatients visiting a tertiary hospital based in midwestern Nigeria.Extended-spectrum β-lactamases producing Klebsiella pneumoniae isolated in two hospitals in Goiânia/Brazil: detection, prevalence, antimicrobial susceptibility and molecular typing.Distribution and antimicrobial susceptibility pattern of bacterial pathogens causing urinary tract infection in urban community of meerut city, India.Species differences in ciprofloxacin resistance among Gram-negative bacteria: can "anti-mutant" ratios of the area under the concentration-time curve to the MIC be achieved clinically?Emergence of co-production of plasmid-mediated AmpC beta-lactamase and ESBL in cefoxitin-resistant uropathogenic Escherichia coli.Prevalence and pathogenesis of extended-spectrum beta-lactamase producing Escherichia coli causing urinary tract infection in hospitalized patients.Evaluation of the discriminatory powers of the Dienes test and ribotyping as typing methods for Proteus mirabilis.ANTIBIOFILM EFFECTS of Citrus limonum and Zingiber officinale Oils on BIOFILM FORMATION of Klebsiella ornithinolytica, Klebsiella oxytoca and Klebsiella terrigena SPECIES.First-Line Antimicrobial Resistance Patterns of Escherichia coli in Children With Urinary Tract Infection in Emergency Department and Primary Care Clinics.A simple and sensitive high-performance liquid chromatography method for determination of ciprofloxacin in bioavailability studies of conventional and gastroretentive prolonged-release formulations.Antibiotic resistance in Citrobacter spp. isolated from urinary tract infection.Antibiotic resistance of uropathogens isolated from Al-Shifa hospital in Gaza Strip in 2002.Efficacy and safety of ciprofloxacin oral suspension versus trimethoprim-sulfamethoxazole oral suspension for treatment of older women with acute urinary tract infection.Phenotypic and genotypic evaluation of beta-lactamases (ESBL and KPC) among enterobacteria isolated from community-acquired monomicrobial urinary tract infections.Comparison of the minimum inhibitory, mutant prevention and minimum bactericidal concentrations of ciprofloxacin, levofloxacin and garenoxacin against enteric Gram-negative urinary tract infection pathogens.Prevalence and antibiotic susceptibility of Uropathogens from cases of urinary tract infections (UTI) in Shashemene referral hospital, Ethiopia.In vitro susceptibility of community-acquired urinary tract pathogens to commonly used antimicrobial agents in Spain: a comparative multicenter study (2002-2004).
P2860
Q33780133-13FF1E01-51F8-454F-A80A-4043E1626B9DQ33982041-18259249-80F4-408C-8EB2-C0306D8254F5Q34123760-D8484B48-D6F7-483F-93F0-78D630155FA0Q34241037-1ECA16B5-126B-4FEB-BC22-30C907D5B454Q34617972-5F9D0222-C292-4D3D-95F3-4868F2CD8394Q35102631-AF002A51-EE85-499C-8E14-D022E3B87F43Q35657071-696F9A1E-56C1-4DB1-8999-0237CE5B5965Q35964763-4450310D-7274-42A4-8D6D-8E8079798039Q35993875-BBD3D5BC-1495-4249-88EB-C5DE73DF9B45Q36150606-A9AF6E98-A3AB-4E86-84EB-A8527CCDAB63Q36458378-C29BA44F-8BAB-4C98-ABB4-C393B25A6950Q36647553-0E819581-7800-4DC3-B772-D381F2307698Q37159257-11023D94-1C94-42FE-AB77-979E16B244A6Q37316260-298B299A-9D50-4297-8413-1EB37E5DA436Q38740127-3A73EFE6-FE23-4A1F-AEFE-A32589C34F69Q39022423-FAE8ADE4-CF66-4127-8E8D-FFA704B63E5FQ39325891-A56C76AD-BCA9-4D34-98DE-BD7BF9441720Q39456063-8D54C459-8268-4C59-A681-2477503887A4Q40222634-2D2362A6-9CA9-4B12-AE6A-6D5E1CFA16B6Q41186943-37AF176C-6AF3-47D6-8279-196FC9541391Q42026066-142815C8-12F1-4AE5-84C5-A2587ADF18F5Q42241962-E4CEB348-7759-4D65-B30D-0C1BCEEFA2DAQ43693445-FBFDA6AF-DD93-4F5F-8B29-77F4EA330796Q43885717-6DD1824E-8A0F-4E41-B438-0CAD21A6ED3CQ45850774-5617937F-96CD-40CD-B0A6-C0B79B1BDBE8Q46832047-F59D3DCC-703E-4354-809B-590919E0B640Q49926470-E44F5265-1ED8-43FA-82EE-5B58A385AA43Q54439040-AE76AFA1-0BA2-4F2F-B4E8-F66FC9DDDFF5
P2860
Activity and spectrum of 22 antimicrobial agents tested against urinary tract infection pathogens in hospitalized patients in Latin America: report from the second year of the SENTRY antimicrobial surveillance program (1998).
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh
2000年學術文章
@zh-hant
name
Activity and spectrum of 22 an ...... l surveillance program (1998).
@en
Activity and spectrum of 22 an ...... microbial surveillance program
@nl
type
label
Activity and spectrum of 22 an ...... l surveillance program (1998).
@en
Activity and spectrum of 22 an ...... microbial surveillance program
@nl
prefLabel
Activity and spectrum of 22 an ...... l surveillance program (1998).
@en
Activity and spectrum of 22 an ...... microbial surveillance program
@nl
P2093
P2860
P356
P1476
Activity and spectrum of 22 an ...... l surveillance program (1998).
@en
P2093
Pfaller MA
P2860
P304
P356
10.1093/JAC/45.3.295
P407
P577
2000-03-01T00:00:00Z